Sort
85,873 grants matching “alzheimers”
CTE and Posttraumatic Neurodegeneration: Neuropathology and Ex Vivo Imaging
$1,496,457Ann Carolyn McKee · Boston University Medical Campus · U01 · FY2016 · NS
Commercialization of Selective Dyrk1a Inhibitors for Down Syndrome
$1,496,403Travis Dunckley · Iluminos Therapeutics, Llc · R44 · FY2024 · NS
Health of the Cholinergic System and Risk for Alzheimer's Disease in Postmenopausal Women
$1,496,380Julie A Dumas · University Of Vermont & St Agric College · R01 · FY2022 · AG
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
$1,496,347Daniel Woo · University Of Cincinnati · U01 · FY2016 · NS
GMP Production of a Tau Oligomer Inhibitor to Enable Clinical Development forADRD
$1,496,276James G. Moe · Oligomerix, Inc · R44 · FY2023 · AG
ALZHEIMER DISEASE RESEARCH CENTER
$1,496,245University Of Pittsburgh At Pittsburgh · P50 · FY2002 · AG
Genetic Epidemiology of Alzheimer's Disease in African Americans
$1,496,207Jennifer Jaie Manly · Columbia University Health Sciences · R01 · FY2007 · AG
Enhancing Sleep Quality for Nursing Home Residents with Dementia: Pragmatic Trial
$1,495,921A Lynn Snow · University Of Alabama In Tuscaloosa · R33 · FY2025 · AG
Lambda Genetic Networks and Lambda Red-Mediated Recombination
$1,495,905Donald Court · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Genetic Epidemiology of Alzheimer's Disease in African Americans
$1,495,863Jennifer Jaie Manly · Columbia University Health Sciences · R01 · FY2008 · AG
Pacific Udall Center
$1,495,767Thomas J Montine · Stanford University · P50 · FY2019 · NS
A double-blinded, randomized, controlled phase 2a safety, proof-of-concept and exploratory end point trial of the drug LM11A-31 in patients with mild to moderate Alzheimer's disease.
$1,495,447Manfred Windisch · Pharmatrophix, Inc. · R01 · FY2018 · AG
Neurobiology and Cognitive Impairment Of The Elderly
$1,495,418Rush University Medical Center · P01 · FY2002 · AG
Neurobiology and Cognitive Impairment Of The Elderly
$1,494,044Rush University Medical Center · P01 · FY2004 · AG
Chemical Coding Of Neurotransmission
$1,493,463Lee E. Eiden · National Institute Of Mental Health · ZIA · FY2010 · MH
Differential Effects of Exercise Modality on Cognition and Brain in Older Adults
$1,493,224Eric Dennis Vidoni · University Of Kansas Medical Center · R01 · FY2024 · AG
Indigenous Cultural Understandings of Alzheimer's Disease and Related Dementias - Research and Engagement (I-CARE)
$1,492,919Kristen Jacklin · University Of Minnesota · R01 · FY2024 · AG
Development of a small-molecule that enhances tripartite synapses for Alzheimers disease
$1,492,896Chien-Liang Glenn Lin · Ohio State University · U01 · FY2021 · AG
Molecular Chaperones and DNA Replication
$1,492,861Sue H Wickner · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Novel Reengineered Microbiome-based Biologic Therapy to Treat Cognitive and Behavioral Symptoms of Alzheimer's Disease and Related Dementias
$1,492,444Anumantha Gounder Kanthasamy · University Of Georgia · U01 · FY2024 · AG
Pathologic protein folding and human disease
$1,492,273David B. Teplow · University Of California Los Angeles · P01 · FY2007 · AG
Impact of Depression on Alzheimer's disease: Prenatal Immune Origins and Shared Impact of Sex
$1,492,211Jill M Goldstein · Massachusetts General Hospital · R01 · FY2019 · AG
California National Primate Research Center
$1,492,200Prasant Mohapatra · University Of California At Davis · P51 · FY2020 · OD
The biological underpinnings of Motoric Cognitive Risk syndrome: a multi-center study
$1,491,998Joe Verghese · Albert Einstein College Of Medicine · R01 · FY2023 · AG
DNA Damage and Neurodegeneration in the Aging Brain
$1,491,737Bruce A Yankner · Harvard Medical School · P01 · FY2009 · AG